COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?—An Insight from the GeroCovid Registry

MLA

Fumagalli, Stefano, et al. “COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?—An Insight from the GeroCovid Registry.” Thrombosis and Haemostasis, vol. 122, no. 1, Jan. 2022, pp. 105–12. EBSCOhost, https://doi.org/10.1055/a-1503-3875.

APA

Fumagalli, S., Trevisan, C., Del Signore, S., Pelagalli, G., Volpato, S., Gareri, P., Mossello, E., Malara, A., Monzani, F., Coin, A., Bellelli, G., Zia, G., & Antonelli Incalzi, R. (2022). COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?—An Insight from the GeroCovid Registry. Thrombosis and Haemostasis, 122(1), 105–112. https://doi.org/10.1055/a-1503-3875

Chicago

Fumagalli, Stefano, Caterina Trevisan, Susanna Del Signore, Giulia Pelagalli, Stefano Volpato, Pietro Gareri, Enrico Mossello, et al. 2022. “COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?—An Insight from the GeroCovid Registry.” Thrombosis and Haemostasis 122 (1): 105–12. doi:10.1055/a-1503-3875.